Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,409.50Prev. Close
1,413.80Volume
6,56,989Total traded value
90.34 CrUpper Circuit
1,696.50Lower Circuit
1,131.10Fundamentals
| Market Cap | ₹22,992Cr |
| ROE | -1.08% |
| P/E Ratio(TTM) | -450.62 |
| EPS(TTM) | -3.14 |
| P/B Ratio | 5.03 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.63 |
| Book Value | 281.07 |
| Debt to Equity | 0.46 |
| Face Value | 5 |
Understand Fundamentals
Financials
About WOCKHARDT Limited
Wockhardt is a global pharmaceutical and biotech company focused on antibiotic research, developing innovative medicines to fight drug-resistant infections. The company's mission is to save lives across the world by creating new antibiotics to tackle the growing global health crisis of antimicrobial resistance. It is the only company in the world where the USFDA has granted special status for six of its anti-bacterial discovery programmes.;
| Parent Organisation | WOCKHARDT Limited |
| Managing Director | Dr. Murtaza Habil Khorakiwala |
| NSE Symbol | WOCKPHARMA |
Shareholding Pattern
Nov '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 86.40 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.18 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.65 | ||
| Concord Biotech | NA (0.00%) | 43.13 |